STANLEY T CROOKE
CIK 897667 · Exec Chairman of the Board · last filed 2021-01-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$36.37M
Companies
3
Total Filings
113
Lifetime Open-Market Net
-$90.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | Exec Chairman of the Board | 496,412 | $73.28 | $36.37M | -$50.31M | 51 | 2021-01-28 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | Chairman and CEO | 32,776 | — | — | -$42.81M | 60 | 2015-10-23 |
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 7,049,500 | $8.16 | $57.52M | $3.00M | 2 | 2012-11-07 |
Recent Filings · Page 12 of 12
113 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-11-30 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$770.3K | EDGAR |
| 2007-07-03 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-01-04 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 111–113 of 113
Prev
Page 12 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.